Qiuji Shao1, Qiaowei Wu1, Qiang Li2, Tianxiao Li1, Li Li1, Kaitao Chang1, Meiyun Wang2. 1. Department of Cerebrovascular Disease, Zhengzhou University People's Hospital, Henan Provincial People's Hospital and Henan University People's Hospital, Zhengzhou, China. 2. Department of Radiology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital and Henan University People's Hospital, Zhengzhou, China.
Abstract
Object: Follow-up evaluation of intracranial aneurysms treated by flow-diverting stents using MRI is challenging due to the presence of imaging artifacts. This study evaluated 3D T1-SPACE in combination with 3D-TOF sequence for follow-up evaluation of intracranial aneurysms treated with Pipeline embolization devices. Methods: Forty patients with 53 intracranial aneurysms who were treated with Pipeline Embolization Devices from October 2018 to July 2019 were enrolled in this study. All patients were evaluated for aneurysm occlusion and stent patency 4 to 7 months post-treatment using 3D T1-SPACE sequence, 3D-TOF MRA, and DSA examinations. Results: With regards to aneurysm occlusion, the intermodality (DSA and 3D-TOF MRA) agreement was good (κ = 0.755). The specificity of 3D-TOF MRA was 94.4% (34/36), the sensitivity was 76.5% (13/17), the total coincidence rate was 88.7% (47/53). With regards to the patency of the stented arteries after PED treatment, 3D T1-SPACE sequence was more accurate compared to 3D-TOF MRA (Z = -6.283, P < 0.001), with a no-artifact rate of 95.7% (44/46). Conclusions: 3D T1-SPACE sequence provides better image quality and higher accuracy for evaluating stented parent arteries compared to TOF-MRA. 3D-TOF MRA may be valuable in the evaluation of aneurysm occlusion. The combination of these two modalities may be used for long-term follow-up of intracranial aneurysms treated with Pipeline Embolization Devices.
Object: Follow-up evaluation of intracranial aneurysms treated by flow-diverting stents using MRI is challenging due to the presence of imaging artifacts. This study evaluated 3D T1-SPACE in combination with 3D-TOF sequence for follow-up evaluation of intracranial aneurysms treated with Pipeline embolization devices. Methods: Forty patients with 53 intracranial aneurysms who were treated with Pipeline Embolization Devices from October 2018 to July 2019 were enrolled in this study. All patients were evaluated for aneurysm occlusion and stent patency 4 to 7 months post-treatment using 3D T1-SPACE sequence, 3D-TOF MRA, and DSA examinations. Results: With regards to aneurysm occlusion, the intermodality (DSA and 3D-TOF MRA) agreement was good (κ = 0.755). The specificity of 3D-TOF MRA was 94.4% (34/36), the sensitivity was 76.5% (13/17), the total coincidence rate was 88.7% (47/53). With regards to the patency of the stented arteries after PED treatment, 3D T1-SPACE sequence was more accurate compared to 3D-TOF MRA (Z = -6.283, P < 0.001), with a no-artifact rate of 95.7% (44/46). Conclusions: 3D T1-SPACE sequence provides better image quality and higher accuracy for evaluating stented parent arteries compared to TOF-MRA. 3D-TOF MRA may be valuable in the evaluation of aneurysm occlusion. The combination of these two modalities may be used for long-term follow-up of intracranial aneurysms treated with Pipeline Embolization Devices.
Authors: M J van Amerongen; H D Boogaarts; J de Vries; A L M Verbeek; F J A Meijer; M Prokop; R H M A Bartels Journal: AJNR Am J Neuroradiol Date: 2013-09-05 Impact factor: 3.825
Authors: Kartik Dev Bhatia; Hans Kortman; Emanuele Orru; Jesse M Klostranec; Vitor M Pereira; Timo Krings Journal: J Neurointerv Surg Date: 2019-05-30 Impact factor: 5.836
Authors: R Irie; M Suzuki; M Yamamoto; N Takano; Y Suga; M Hori; K Kamagata; M Takayama; M Yoshida; S Sato; N Hamasaki; H Oishi; S Aoki Journal: AJNR Am J Neuroradiol Date: 2014-12-18 Impact factor: 3.825
Authors: Seby John; Mark D Bain; Ferdinand K Hui; M Shazam Hussain; Thomas J Masaryk; Peter A Rasmussen; Gabor Toth Journal: Neurosurgery Date: 2016-06 Impact factor: 4.654
Authors: J Burel; E Gerardin; M Vannier; A Curado; M Verdalle-Cazes; N Magne; M Lefebvre; C Papagiannaki Journal: AJNR Am J Neuroradiol Date: 2022-03-03 Impact factor: 3.825